FDA's Forthcoming Drug Development Guidance: It's All About The Process
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA's forthcoming draft guidance on qualification of drug development tools - a voluntary process for sponsors - will focus on methods rather than specific means